A male infant with COVID-19 in the context of ARPC1B deficiency

Pediatr Allergy Immunol. 2021 Jan;32(1):199-201. doi: 10.1111/pai.13322. Epub 2020 Sep 2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Actin-Related Protein 2-3 Complex / deficiency*
  • Actin-Related Protein 2-3 Complex / genetics
  • Anti-Infective Agents / therapeutic use
  • COVID-19 / complications*
  • COVID-19 / genetics
  • COVID-19 / therapy
  • Hospitalization
  • Humans
  • Immunologic Deficiency Syndromes / complications*
  • Immunologic Deficiency Syndromes / therapy
  • Infant
  • Male
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • ARPC1B protein, human
  • Actin-Related Protein 2-3 Complex
  • Anti-Infective Agents